ARE Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Alexandria Real Estate Equities Inc (ARE) is not a strong buy for a beginner, long-term investor at this moment. The stock shows limited positive catalysts, weak technical indicators, and ongoing challenges in the life sciences real estate sector. While the dividend yield and long-term potential may be attractive, the current market sentiment and financial performance suggest waiting for clearer signs of recovery or improved fundamentals.
The technical indicators are neutral to bearish. The MACD is below zero and negatively contracting, RSI is neutral at 62.326, and moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading near resistance levels (R1: 54.937, R2: 56.157), suggesting limited short-term upside potential.
The stock has a 5.27% chance of increasing in the next month based on historical candlestick patterns. Additionally, the dividend yield remains stable at 4%, which could appeal to long-term investors.
Analyst ratings are largely neutral with reduced price targets, citing systemic pressures in the life sciences industry and oversupply in the lab space market. Financial performance has been weak, with a significant YoY revenue drop (-18.13%) and negative EPS (-6.35). Gross margin has also declined sharply (-42.67% YoY).
In Q4 2025, revenue dropped by 18.13% YoY to $672.16 million. Net income showed a significant increase to -$1.08 billion, but this is due to adjustments rather than operational improvement. EPS increased to -6.35, but gross margin fell to 17.49%, indicating operational challenges.
Analyst sentiment is neutral to cautious. Price targets have been revised downward by multiple firms, with limited visibility into earnings growth and concerns about the life sciences real estate market. The most optimistic target is $67, while the lowest is $45, reflecting uncertainty in the stock's recovery timeline.
